Global Increase in Cardiovascular Disorders, Combined with Advances in Diagnostic Procedures, is Boosting Demand for Cardiovascular Diagnostic Products, Resulting in a Robust Industry: Future Market Insights

The global cardiovascular diagnostics market is expected to grow at a significant rate in the coming years, driven by several factors including increasing rising tobacco consumption around globe. The increase cardiovascular diseases (CVD) globally, will drive the global market from USD 5.9 Billion in 2023, to USD 9.7 Billion by the end of 2033. The market is projected to expand at a CAGR of 5.1% over the forecast period (2023-2033).

The global market for cardiovascular diagnostics is expanding rapidly due to a variety of causes. The increased prevalence of cardiovascular disorders, developments in diagnostic techniques such as electrocardiogram (ECG), and rising demand for quick and simple diagnostic tests are propelling the market forward.

By developing new imaging technologies, portable diagnostic gadgets, and molecular diagnostic techniques, manufacturers can innovate and improve patient care. Furthermore, the use of data analytics and AI algorithms improves diagnostic accuracy and clinical decision-making. However, problems such as a shortage of skilled staff, budgetary constraints, and insufficient regulations and policies are limiting market expansion.

The market experienced growth in 2021, surpassing initial projections before the COVID-19 pandemic. Since the emergence of COVID-19 three years ago, over 750 million individuals worldwide have been affected by the disease. Recent studies have indicated that certain individuals who have contracted COVID-19 are at a higher risk of developing cardiovascular conditions like irregular heartbeat, stroke, and heart failure.

The connection between COVID-19 and cardiovascular disease has been observed, highlighting the potential long-term impact of the virus on cardiovascular health. This correlation emphasizes the importance of addressing and monitoring the cardiovascular health of individuals who have had COVID-19, as well as the need for continued research and advancements in cardiovascular diagnostics and treatments to mitigate the potential consequences of the disease. Overall, the cardiovascular diagnostic market is likely to expand in the next years, offering a cost-effective and simple option for patients suffering from CVDs.

Key Takeaways from Market Study:

  • Electrocardiogram (ECG) systems holds a significant market share of 4% in the global cardiovascular diagnostics market in 2022 due to prominence of ECG systems globally.
  • Hospitals take away the larger share among all end user due to availability of most of diagnostic products and equipment in the hospitals. The segment held around 5% value share in 2022.
  • The North America region accounts for the dominant market share at 4%, with a market value of USD 2.1 Billion in 2022 owed to strong market presence of key players in North America contributing to the overall advancement and expansion of the cardiovascular diagnostics market.

“The increasing global prevalence of cardiovascular disease has led to a growing demand for CVD diagnostics in recent years, this presents a favourable opportunity for entry into the cardiovascular disease diagnostic market.” says an analyst of Future Market Insights.

Rising Demand for Market Data: Our Full Report Offers Deep Insights and Trend Analysis!

Market Competition:

The cardiovascular diagnostic industry is extremely competitive, with GE Healthcare and Abbott Laboratories among the leading participants. To achieve a greater market share, these firms are continually reinventing their goods and marketing techniques, with an emphasis on price, convenience, and efficacy.

  • In February 2023, GE HealthCare aims to revolutionize ultrasounds by making them accessible worldwide, as demonstrated by their recent acquisition of Caption Health, an AI software company specializing in cardiac imaging.
  • In September 2022, SRL Diagnostics introduces ‘Heart Assure’, a specialized blood test using high sensitivity Troponin I to accurately predict the risk of cardiac events.

Key Companies Profiled:

  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG
  • Schiller, Koninklijke Philips N.V.
  • GE Healthcare and Wayra
  • Siemens Healthcare
  • Lepu Medical
  • Midmark Corp
  • Roche Ltd
  • Randox Laboratories Ltd.
  • Robonik India
  • Diasorin
  • Elabscience Biotechnology

Key Market Segments Covered in the Cardiovascular Diagnostics Industry Research:

By Product:

  • Electrocardiogram (ECG) system
  • Resting ECG Systems
  • Cardiopulmonary Stress Testing Systems
  • Holter Monitoring Devices
  • Event Monitoring Devices
  • Implantable Loop Recorder (ILR)
  • Others

By Point-of-Care Testing:

  • Analyzers
  • Lipoprotein Test Kits
  • Angiotensin Test Kits
  • Fibrinogen Test Kits
  • Serum Uric Acid Test Kits
  • High-Sensitivity CRP (hs-CRP) Kits

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Cardiac Catheterization Labs
  • Diagnostic Imaging Centers

By Region:

  • North America
  • Latin America
  • East Asia
  • South Asia & Pacific
  • Europe
  • Central Asia
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Chronic Brain Damage Management Market Set to reach Projected to Reach USD 1.77 Billion by 2033, Driven by Accelerating Demand for Advanced Solutions | FMI

Future Market Insights (FMI) has unveiled a pioneering market analysis indicating that the global chronic brain damage management market is on track for remarkable growth over the next decade. Valued at USD 0.9 billion in 2023, the market is projected to nearly double, reaching USD 1.77 billion by 2033. This impressive expansion reflects a robust compound annual growth rate (CAGR) of 7%, a substantial increase from the 3.5% CAGR recorded between 2018 and 2022.

This surge in market growth underscores a significant shift in the demand for advanced solutions in managing chronic brain injuries and neurological disorders. The escalating global incidence of conditions such as stroke, traumatic brain injury, and cerebral palsy is a major driver of this growth. The World Health Organization (WHO) reports that strokes affect approximately 15 million people annually, while traumatic brain injuries impact an estimated 69 million individuals each year. This alarming prevalence highlights the urgent need for innovative therapies and comprehensive management strategies.

As the global population ages and lifestyle factors evolve, the demand for effective chronic brain injury management is anticipated to increase even further. This presents a significant opportunity for industry stakeholders to develop and introduce groundbreaking solutions aimed at improving patient outcomes and enhancing quality of life.

The increased pace of market expansion reflects the global healthcare community’s commitment to advancing the diagnosis, treatment, and rehabilitation of individuals affected by chronic brain injuries. Industry leaders and innovators are well-positioned to drive these transformative changes through collaborative efforts and cutting-edge research.

Future Market Insights’ analysis signals a new era of progress in neurological care, with promising advancements on the horizon that are set to reshape the landscape of chronic brain damage management.

Key Takeaways from the Market Study:

  • The Chronic Brain Damage Management market expanded at a CAGR of 3.5% from 2018 to 2022.
  • The market for managing chronic brain damage is anticipated to expand at a 7% CAGR from 2023 to 2033.
  • The market for managing chronic brain damage is anticipated to reach USD 1.77 billion by 2033.
  • The hospital sector holds the biggest market share, per the FMI research.
  • For the Chronic Brain Damage Management market, North America is predicted to have a 40% market share.
  • With a share of 20% throughout the projection period, it is expected that the East & South Asia market would grow considerably.

“A series of international level collaborations involving healthcare stakeholders across various institutional settings are fueling further clinical trials and research studies dedicated to discovering Chronic Brain Damage Management.” says an FMI analyst

Explore the High Demand for Chronic Brain Damage Management: Our Full Report Provides a Detailed Look at Emerging Trends!

Market Competition:

Key players in the market include companies such as NeuroVive Pharmaceutical AB, TEVA Pharmaceutical Industries Ltd., Integra LifeSciences Corporation, Medtronic PLC, Neuren Pharmaceuticals Ltd., Johnson & Johnson Services Inc., Smith & Nephew, Stryker, B.Braun Melsungen AG, Neural Analytics, Inc., along with healthcare providers and technology companies among other global players.

  • In August 2022, a study revealed that Abbott’s blood test for concussion has the potential to predict outcomes from brain injury and inform treatment interventions. The test measures levels of two biomarkers, Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin carboxy-terminal Hydrolase L1 (UCH-L1), in blood plasma within 24 hours of injury. High levels of GFAP and UCH-L1 were found to correlate with death and severe injury, and the test could accurately predict such outcomes six months after the injury. The study suggests that clinicians could use this test to get a more accurate picture of the severity of the injury and the expected course of recovery, enabling them to provide the best care for patients. Abbott is currently seeking FDA clearance for its TBI test on Alinity i and ARCHITECT core laboratory instruments, and the test is already CE Marked and available outside the U.S.

Key Segments Profiled in the Chronic Brain Damage Management Industry Survey:

Diagnosis:

  • Imaging studies
  • Blood tests
  • Brain evaluations

Treatment Type:

  • Occupational therapy
  • Physical therapy
  • Psychotherapy
  • Speech or language therapy

End- User:

  • Hospitals
  • Neurology Clinics
  • Independent Pharmacies

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Chiari Malformation Treatment Market Poised for Significant Growth, Reaching USD 4.2 Billion by 2033 registering a CAGR of 6.4%

According to a recent study conducted by Future Market Insights, the global chiari malformation treatment market, valued at USD 2.26 billion in 2023, is anticipated to witness substantial growth over the next decade. Projections suggest a robust Compound Annual Growth Rate (CAGR) of 6.4%, with the market expected to reach approximately USD 4.2 billion by 2033.

Chiari malformation, a condition characterized by the displacement of brain tissue into the spinal canal, has historically presented significant challenges in management. However, recent advancements in medical science have revolutionized the landscape of diagnosis and treatment. Enhanced diagnostic capabilities, driven by technological innovations, now facilitate earlier and more precise detection of Chiari malformation. This pivotal development enables healthcare providers to initiate timely interventions, thereby improving patient outcomes.

Surgical intervention remains a cornerstone of Chiari malformation treatment, particularly for patients exhibiting severe symptoms or complications. Among the surgical options, decompression surgery, which involves removing part of the skull to give more room to the cerebellum, is commonly pursued. Additionally, spinal fusion surgery is another therapeutic option available to stabilize the spine and prevent further damage, highlighting the surgical advancements contributing to market growth.

The report from Future Market Insights underscores a pivotal shift towards better diagnostic and treatment approaches, which not only promise improved patient outcomes but also drive market expansion. As awareness and technology continue to advance, the Chiari malformation treatment market is set for significant expansion in the coming years.

Healthcare providers, patients, and stakeholders in the medical community are encouraged to stay informed about the developments in this field, as ongoing innovations and the introduction of new treatment modalities are expected to further enhance patient care and market growth.

Key Takeaways from the Market Study:

  • The Chiari malformation treatment market is expected to grow at a value of 6.4% CAGR in the forecast period 2023-2033
  • By treatment, surgical treatment is expected to possess 60% market share for Chiari malformation treatment market in 2023.
  • Europe is expected to possess 40% market share for Chiari malformation treatment market in 2023.
  • North America is expected to possess 45% market share for Chiari malformation treatment market in 2023.

“Ongoing research into the use of non-invasive techniques such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) are expected to improve symptoms of Chiari Malformation. This, in turn, will drive the growth of the market.” states an FMI analyst

Rising Interest in Market Trends: Our Detailed Report Provides Essential Insights!

Competitive Landscape:

Key players in the Chiari malformation treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Mylan N.V., Hikma Pharmaceuticals PLC, Novartis AG, Fresenius Kabi AG, Teva Pharmaceutical Industries Ltd., Bristol Myers Squibb Company, Bayer AG, Sun Pharmaceutical Industries Ltd

  • Mylan’s generic version of the pain medication gabapentin has been approved by the US Food and Drug Administration (FDA) to treat neuropathic pain, which can be a symptom of Chiari Malformation.
  • Hikma’s generic version of the pain medication gabapentin has been approved by the US Food and Drug Administration (FDA) to treat neuropathic pain, which can be a symptom of Chiari Malformation

Key Segments Profiled in the Chiari Malformation Treatment Market Survey:

Type:

  • Type 1
  • Type 2
  • Type 3
  • Type 4

Treatment:

  • Medical Treatment
  • Surgical Treatment

Diagnosis:

  • MRI
  • Cine MRI
  • X-rays
  • CT-Scan

End User:

  • Hospitals
  • Surgical Centres
  • Research Institutes
  • Specialty Clinics

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Hydration Boosters Market Shaping the Future of Functional Beverages and Supplements

According to a recent industry analysis conducted by Future Market Insights, Inc., a leading market research and competitive intelligence provider, global hydration boosters market is projected to grow significantly, with an estimated valuation of USD 8.8 billion in 2024 and a forecasted rise to USD 19.5 billion by 2034, driven by a CAGR of 8.3% over the period. This growth is fueled by changing consumer preferences, a focus on health-conscious products, and innovative marketing strategies, such as influencer partnerships and social media campaigns.

Key industry trends include the increasing popularity of calorie- and sugar-free hydration solutions, particularly flavored options like apple, citrus, and watermelon, which enhance both taste and health benefits. The market is also benefiting from the demand for convenient, portable product formats, such as powdered solutions, liquid concentrates, and single-serving packets, which cater to busy consumers and athletes.

“Analyze the projected growth of the global hydration boosters market, focusing on the impact of innovative product development, changing consumer preferences, and the increasing demand for sugar-free and calorie-free options on the market’s CAGR of 8.3% over the 2024-2034 period.”- says Nandini Roy Choudhury, Client Partner at Future Market Insights 

The sector is evolving with the introduction of multifunctional hydration products that support energy boosts, immune health, and skin wellness, incorporating ingredients like collagen, caffeine, and vitamins. The rising consumer interest in holistic wellness is driving the popularity of these products.

As global temperatures rise and active lifestyles become more common, the need for effective hydration solutions is growing, particularly in regions like the U.S., Germany, and India. In the U.S., for example, the market is expected to reach USD 3.4 billion by 2034, driven by trends in fitness and preventive healthcare. Germany is also seeing increased demand for hydration products, particularly among its elderly population.

Competition Outlook

The global business landscape of hydration relief products revolves around the rising consumer appetite, the trend of preventive healthcare, and product innovation. Attractive packaging, the infusion of natural healthy ingredients, and the widespread distribution network attract companies to increase their market share.

These strategies are not only helping the companies to increase their revenue but also increasing their consumer base and brand attraction among consumers. Key companies in the global industry are narrowing down their product strategy by including clean-label solutions in their portfolio to attract health-conscious consumers. These companies emphasize sustainability and infuse unique ingredient formulations into their products.

These marketing strategies and product innovations help the key players to increase their sales across the globe. Increasing investment in research and development and widespread online distribution attract manufacturers and brands to increase their sales in the global industry. Companies are coming up with different solutions for different applications to gain consumer attraction.

For Instance

  • In October 2023 BODYARMOR Sports Nutrition company launched the “Bodyarmor Flash I.V.” in powder and bar form in the rapid rehydration category. According to the company, this product with added minerals and vitamins will help the consumers to stay hydrated.
  • In April 2024, Evocus company launched the four popular flavors of the products to keep them competitive in the global business landscape.

Leading Manufacturers

  • MOONFREEZE FOODS PRIVATE LIMITED
  • SEEverse
  • HydroMate
  • Liquid I.V.
  • Espri Life
  • Venture Pal
  • Drip Drop Hydration Inc
  • EVLUTION NUTRITION
  • Adapted Nutrition
  • Hydralyte
  • Equalan Pharma
  • OFFSPRING BEAUTY CO
  • Lipoid-Kosmetik

Key Segments of the Report

By Product Type:

Key product types like Powdered Hydration boosters, Liquid Concentrates, Hydration Gels, and Serum are included in the report

By Flavor:

Key flavors like Watermelon, Citrus, Green Apple, Berries, and others are considered in the report.

By End Use:

This segment has been categorized into Improve Hydration, Skin Health, Energy Boost, Immune Support, and others.

By Sales Channel:

Industry analysis has been carried out in different sales channels as store-based retailing (Supermarkets/Hypermarkets, Departmental Stores, Convenience Stores, Other Sales Channel) and online retailing (Company Website, E-commerce Platform).

By Region:

Industry analysis has been carried out in key countries of North America, Latin America, Europe, Middle East and Africa, East Asia, South Asia, and Oceania

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Coagulants Market Driving Innovations in Dairy and Food Processing Industries

The global coagulants market is experiencing robust growth, with a projected value of USD 5,839.1 million by 2034, up from USD 3,719.2 million in 2024. The market is expected to expand at a compound annual growth rate (CAGR) of 5.7%, driven by increasing demand for water and wastewater treatment solutions across various industries. Coagulants, essential chemicals used to remove suspended solids from water, are pivotal in addressing water quality challenges, particularly in urbanizing regions.

Coagulants is a chemical with Positive charge and remove solid from water. Coagulants sector experiencing significant growth driven by increasing demand for water treatment solution, industrial processes and wastewater management.

The growth of industries such as pulp and paper, mining, and oil and gas is significantly boosting the demand for coagulants across various applications. These sectors deeply rely on water-intensive processes, generating substantial amounts of wastewater that require effective treatment to meet regulatory standards. In the pulp and paper industry, coagulants are essential for clarifying process water and recovering pulp, ensuring that the production methods are efficient and environmentally compliant.

Coagulant manufacturers are increasingly offering modified formulations to meet the specific needs of their customers in various industries. As water treatment requirements vary depending on the water’s source, arrangement, and intended use, a one-size-fits-all approach is often insufficient. Manufacturer’s help to consumer achieve optimal performance and efficiency in their water treatment processes by providing tailored coagulant solutions.

Key Takeaways

  • Sales of Coagulants for Water & Wastewater Treatment are projected to register a CAGR of 7.3% from 2024 to 2034.
  • Sales of powder form are projected to register a CAGR of 6.7% from 2024 to 2034.
  • The Asia-Pacific region is expected to lead market growth due to rapid industrialization and urbanization in countries like China and India.
  • Innovations in environmentally friendly coagulants are set to shape the future of the market, with companies investing in sustainable solutions.
  • Water treatment plants, especially in developing regions, are driving demand as governments invest in infrastructure to meet the growing need for potable water.

“Rising global demand for clean water and tighter environmental regulations are propelling the coagulants market, with a noticeable shift towards organic options, as industries prioritize sustainable solutions for effective water treatment.” – says Nandini Roy Choudhury, Client Partner at Future Market Insights 

Key Market Drivers

  • Rising Demand for Water Treatment Solutions: Growing global populations and rapid urbanization, particularly in developing nations such as India and China, are heightening the need for efficient water and wastewater treatment processes. Coagulants play a critical role in addressing water quality, making them indispensable for municipalities and industries alike.
  • Stringent Environmental Regulations: Governments worldwide are enforcing stricter regulations to ensure water quality and prevent contamination. This regulatory push is driving the adoption of coagulants, particularly in industrial sectors that generate significant wastewater, such as mining, oil and gas, and pulp and paper.
  • Technological Advancements: The introduction of advanced coagulant formulations, including organic and hybrid coagulants, is reshaping the market. These sustainable solutions offer enhanced performance, lower sludge production, and reduced environmental impact, aligning with global sustainability trends.
  • India and China Lead Growth: With rising urbanization and industrialization, India and China are set to be key growth drivers in the global coagulants market. India, with its burgeoning population and increasing need for clean water, is expected to see a CAGR of 9.6% through 2034, reaching USD 729.9 million in market value. China’s coagulant market is also poised for rapid growth, with a projected CAGR of 7.5%.
  • United States and Germany: Both nations are expected to remain dominant consumers of coagulants. The United States is forecasted to reach USD 1,255.4 million by 2034, driven by the expansion of industries like oil and gas. Germany, on the other hand, is expected to lead Europe with a market share of 23.5%, focusing on advanced coagulant technologies for industrial and municipal water treatment.

Opportunities and Challenges

The coagulants market presents substantial opportunities, especially in regions where water scarcity and pollution are growing concerns. The demand for customized coagulant formulations is also on the rise, allowing manufacturers to tailor solutions to meet specific industry and water treatment needs. However, the availability of cost-effective alternatives and stringent regulatory frameworks may pose challenges to market growth.

Competition Outlook

The coagulant market is experiencing significant growth, driven by rising urbanization, industrial wastewater generation, and stringent environmental regulations. There are various key players in the industry such as BASF SE (Germany), SNF Group (France), Solenis (USA), Kemira (Finland), Mitsubishi Chemical Holding Company (Japan), Feralco AB (Sweden), Avista Technologies Inc. (USA), ChemTreat Inc. (USA), Buckman (USA), Ecolab (USA), and others.

For example

In 2024, USALCO, LLC a leading provider of water treatment solutions for municipal and commercial customers, announced that it had acquired the coagulant manufacturing business of Brenntag Southwest, Inc.

Who is winning?

The global Coagulants industry is dominated by many big players, BASF SE (Germany), SNF Group (France), Solenis (US), Kemira (Finland), Mitsubishi Chemical Holding Company (Japan), Feralco AB (Sweden), Avista Technologies Inc. (US), ChemTreat Inc. (US) and these business leaders constitute a significant value share. These brands have extensive good manufacturing practices and distinguish themselves from the competitors through an elaborate distribution network and regional presence and also launch new products and merger and acquisition

For instance:

In 2024, USALCO, LLC a leading provider of water treatment solutions for municipal and commercial customers, announced that it had acquired the coagulant manufacturing business of Brenntag Southwest, Inc.

Key Segments of Coagulants Market Report

By Type:

By Type, the segment has been categorized into Organic (PolyDADMACs, Polyamines, Formaldehyde Melamine and Others) and Inorganic (Polyaluminum Chloride, Ferric Chloride, Aluminum Sulfate, PolyaluminumSulfate, Ferric Sulfate, and Others)

By End-Use:

By end use, industry included Water & Wastewater Treatment, Pulp, and Paper, Oil & Gas, Agriculture, and others

By Form:

The form includes powder and Liquid

By Region:

Industry analysis has been carried out in key countries of North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Food Immunomodulators Market A New Frontier in Functional Food Development

The global food immunomodulators industry has an estimated market valuation of USD 430.65 million by 2024. It is projected to grow at a CAGR of 4.2 % to reach a market valuation of USD 652.5 million by 2034.

The food immunomodulators market is increasing and is expected to grow steadily due to the rising incidences of chronic diseases. Conditions such as allergies and diseases like cancer, auto-immune, inflammatory, respiratory diseases in humans, and infectious diseases in animals and various others have contributed to the rise in demand for food-based immunomodulators. Especially, the surge in various variants of COVID-19 has played a major role in the continuous growth and development of the food immunomodulators industry. Companies such as Danone are taking the lead by producing a broader range of product choices for consumers using a wide extent of organic and fortified ingredient sources. Functional non-GMO foods are also making their way, to meet additional health benefits with immune enhancement. Companies such as Nestle have come up with their organic, non-GMO superfoods, thus attracting the attention of a major part of the population and boosting their sales.

Innovations in the fields of biotechnology, genetics, and pharmacology have led to innumerable concerns among a major part of consumers thus persuading them to consume food containing immunomodulators which can provide long-lasting immune-boosting effects and also reduce pathogenic infections.

Improved ranges in the products including flavors, sources, nutritional additives, colors, and packaging have led to a boost in the volume and profits of many companies. Various activities are being employed to further garner attention as well as spread knowledge among the end users.

Key Takeaways from the Global Food Immunomodulators Market Study:

  • Sourcing ingredients via regenerative farming practices, supporting farmers, engaging consumers, and tackling many environmental issues. Bledina, a subsidiary group of Danone, invites consumers to visit farms where the ingredients grow. This practice helps in promoting a sense of trust between the buyers and manufacturers.
  • Optimizing the nutritional value using organic products by leveraging the research and development facilities and targeting certain groups of consumers has surely helped the food immunomodulators industry to rise. Kerry Group, for instance, has introduced probiotics isolated from breast milk which is said to support breast health in lactating mothers and also the immune health system of the infants without compromising any other factors. This has led to the popularity of its products among female parents who are looking out for healthy alternatives.

“Manufacturers who pursue certification and accreditations as well as set up innovation hubs and centers for more R&D in the food immunomodulators industry will enjoy the higher consumer trust and reliability and will move up the market leadership.”, – says Nandini Roy Choudhury, Client Partner at Future Market Insights 

The competitive dynamics in the Food Immunomodulators sector are fuelled by innovation, partnerships, and digitalization, with market players constantly adapting to shifting client demands. Companies are employing technology to provide value-added services with digital technologies. Such platforms enable manufacturers to manage the microbe culture processes in real time, optimize the use of feeds to achieve maximum production, and realize higher productivity. This enhances client relations and broadens the competitive market by creating unique selling points.

Some of these leaders of the Global Food Immunomodulator market are Danone SA, Nestle SA, Yakult Honsha Co., Ltd., ADM, Kerry Group, Cargill Inc., Ingredion Inc., Sabinsa Corporation, BioGaia, Lallemand Inc., Tate and Lyle, Glanbia Nutritionals, Amway Corporation, Bio-Thera Solutions Ltd., and Stratum Nutrition.

For instance:

  • In 2023, Lallemand Inc. introduced a range of protective technologies to ensure proper and optimal survival and efficacy of their probiotic products. For instance, their products are usually bacteria and yeast-based, probiotic supplements, which are highly stable and targeted specifically for immunity and women’s vaginal health.
  • Another company, BioGaia, started providing choices and specifications to the customers for different species and strains that were used to formulate the products as each strain offered unique benefits.

Leading Brands

  • Danone SA
  • Nestle SA
  • Yakult Honsha Co., Ltd.
  • ADM
  • Kerry Group
  • Cargill Inc.
  • DuPont Nutrition and BioSciences

Get valuable insights into the Global Aquaculture Nutrition Market:

Future Market Insights, in its new offering, provides a thorough, detailed, and unbiased analysis of the Global Food Immunomodulators Market, presenting Historical Demand data for the years 2019-2023 and Forecast statistics for the years 2024-2034.

The study categorizes valuable insights into the Global Food Immunomodulators Industry based on Product Type, Ingredient Type, End User demographic type, Application Type, Sales Channel Type, and Region Type. As per product type, the industry has been categorized into Immunostimulants (Prebiotics and Probiotics, Postbiotics, Vitamins, Minerals, Proteins, and Peptides), Immunosuppressants, Functional foods (Fortified dairy products, Fortified cereals, Energy bars), and Others (Amino acids, Phytochemicals) and according to forms include Powders, Tablets, Capsules, and Liquids. As per ingredient type, the industry has been categorized into Plant-based sources (Fruits, Vegetables, Nuts, Herbs, and Spices), Animal-based sources (Fish oils, Bone broth, Egg yolks, Honey), Fermented products (Dairy-based and Non-dairy-based), Mushroom based sources, and Algae based] sources. As per end user demographics, the industry has been divided into Animals (Pets, Ruminants, Poultry, Aquatic, Equines, Bovines, and Pigs) and Human Beings [Age Groups (Children, Adults, Elderly), and Gender (Men and Women)]. Different sales channels include Store-based retail (Hypermarkets, Supermarkets, Convenience stores, Medical stores, and Specialty stores) and Online retail (Company websites, and Third party websites). As per application, this industry has been divided into Nutraceuticals (Anti-inflammatory support, Eye health support, Cardiovascular health support, Mental Health support, Respiratory health support, Gut health support, Disease prevention). The study consists of the following regions- North America, Latin America, Western Europe, Eastern Europe, Balkans & Baltic, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and Middle East & Africa.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Anhydrous Milk Fat Market Expanding Opportunities in Premium Dairy Ingredients

Global Anhydrous milk fat Market is estimated to reach a market valuation of USD 2.8 billion in 2024. Over the Forecast period (2024 to 2034) Baby food products demand is expected to grow at 6.3% CAGR. By 2034 the total market is projected to reach USD 5.2 billion valuations.

The usage of fats in food perception has been a growth factor for the food industry. The nutrition of daily beverages serves as a pivotal product-intrinsic sensory signal, significantly influencing people’s judgments of flavor and taste. Historical practices involved enhancing fats sourced from premium quality of milk. However, the industrialization of milk fat production necessitated reliable and shelf-stable products across all batches.

In recent years, digitization has fuelled rapid expansion across industries globally. The widespread adoption of digitization in the global economy has led to significant growth. Anhydrous milk fat producers leverage online channels for promotion and sales due to the increasing use of the internet and the simplicity of online transactions among consumers. Online merchants are favored by the majority of consumers, driving businesses to establish a strong online presence. Furthermore, emerging trends include specialty stores and bakery and confectionary as additional avenues for reaching consumers.

Cultural preferences and mouth-feeling experience of dairy products are generally major factors for the rising consumption of milk fat. Products are usually made from full cream milk and thickeners which can be helpful in the improvement of shelf stability.

Key Takeaways from the Anhydrous milk fat Market Report:

  • Regularity to changing consumer preferences has led to these manufacture’s reformulating products.
  • Dairy Farmers of America and Fonterra are two of the major players in the AMF industry, and they are considering upgrading production to meet the growing demand globally.
  • Manufacturers are turning their attention to improving nutritive value of foods, precipitating such aspects as higher vitamin content and indispensably, calcium.
  • Regional producers are finding a foothold because of focusing on the target communities; appealing to their cultural and dietary needs.
  • One of the major reasons that make the future development of anhydrous milk fats possible is the developing plant-based diet trend.

“Brands that deliver convenience, value and quality to pet owners at competitive prices will have a competitive advantage and emerge as a leader in the industry.”, says a lead analyst at Future Market Insights”, says Nandini Roy Choudhury, Client Partner at Future Market Insights.

Who is Winning?

The global Anhydrous milk fat market encompasses diversified product portfolios of several key manufacturers across the regions. Leading players in the industry are consistently focusing on increasing their revenue share. From raw material sourcing to converting them as a key ingredient for the end-user industry companies are striving to maintain their supply chain to keep themselves competitive. Key players are also focusing on creating their own raw material sources like exclusive dairy farms to reduce raw material expenses, and reduce the dependency on other resources, such strategies leveraging them to maintain their cash flow and increase the overall growth and revenue.

Leading Manufacturers

  • Dairy Farmers of America
  • Fonterra
  • LACTALIS Ingredients
  • Saputo Dairy Australia Pty Ltd.
  • Synlait Milk Limited
  • Westland Milk Products
  • Meadow Foods
  • Friesland Campina
  • Tatua Co-operative Dairy Company Limited
  • HIROLAND

Get More Valuable Insights

Future Market Insights (FMI), in its new offering, provides an unbiased analysis of the global Caffeine Mints market presenting historical demand data (2019 to 2023) and forecast statistics for the period from 2024 to 2034.

The study incorporates compelling insights on the Anhydrous milk fat market based on Grade (Fat Content 99.8% and Fat Content 99.3%), by packaging format (Tote, Drum, Boxed Bag and Pail), Applications (Bakery, Confectionery, Soups & Sauces, Dairy and Desserts, Snacks, and Others) across various regions.

Key Segments of the Report

By Grade:

Two different grades (Fat Content 99.8% and Fat Content 99.3%) are included in the report.

By Packaging Format:

Packaging formats like Tote, Drum, Boxed Bag and Pail are considered after the exhaustive research.

By End Use Application:

by application industry has been categorised into Bakery, Confectionery, Soups & Sauces, Dairy and Desserts, Snacks, and Others.

By Region:

Industry analysis has been carried out in key countries of North America, Latin America, Europe, Middle East and Africa, East Asia, South Asia, and Oceania.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Texture Modifying Agents Market Enhancing Food Quality and Appeal through Innovation

The global texture modifying agents market, valued at approximately USD 7,012.3 million in 2024, is projected to experience steady growth over the next decade, reaching USD 9,891.5 million by 2034. This represents a compound annual growth rate (CAGR) of 3.5% from 2024 to 2034, driven by rising demand in various industries including food and beverage, pharmaceuticals, and personal care.

As industries continue to expand and diversify, texture modifying agents are essential in enhancing product stability, mouthfeel, and consistency, meeting consumer demands for superior sensory experiences and functional product formulations.

Texture modifying agents play a pivotal role across numerous applications, from thickening and stabilizing to gelation and emulsification. In the food and beverage sector, these agents are critical for improving product quality and shelf stability, allowing manufacturers to meet ever-evolving consumer preferences for specific textures and consistencies.

The market’s expansion is fueled by innovations in clean-label products and plant-based alternatives, both of which are trending globally. In pharmaceuticals and personal care, texture modifiers ensure product efficacy and stability, enhancing user experience and supporting the growth of customized formulations.

Key Takeaways:

  • The texture modifying agents market is forecasted to grow at a CAGR of 3.5% during the 2024-2034.
  • Growth is supported by consumer preferences for enhanced product textures and clean-label solutions, pushing manufacturers to innovate in texture modification technologies.
  • Key players in the market are actively focusing on R&D, seeking to create sustainable and plant-based texture agents that meet regulatory and environmental standards.

“The Texture Modifying Agents Market is witnessing significant growth driven by rising demand across the food, cosmetics, and pharmaceutical industries. With advancements in formulation techniques, these agents are enhancing product appeal and functionality, catering to evolving consumer preferences for improved texture and sensory experiences.”, says Nandini Roy Choudhury, Client Partner at Future Market Insights 

Texture Modifying Agents Industry Challenges

The texture modifying agents market faces certain challenges, primarily related to regulatory standards and the demand for clean-label ingredients. With increasing consumer awareness, there is heightened scrutiny over ingredient lists, pushing manufacturers toward natural and recognizable agents. Additionally, sourcing raw materials for these agents can be constrained by environmental regulations and price volatility. Maintaining consistent product quality while balancing the cost of natural ingredients is a complex task for manufacturers striving to remain competitive.

Texture Modifying Agents Industry Growth Drivers

A major driver of growth in the texture modifying agents market is the rising demand for enhanced sensory attributes in food and personal care products. As consumers become increasingly health-conscious, they look for products that provide specific textural benefits, such as creamy, smooth, or thick consistencies, without artificial additives.

In addition, the shift towards plant-based foods has opened new opportunities, as these products often require texture modifiers to mimic the mouthfeel of traditional animal-based products. Technological advancements in ingredient processing and formulation have also enabled the development of innovative solutions, supporting the market’s expansion.

Key Industry Highlights:

  1. Clean-Label Innovations: Key players are focusing on developing texture modifying agents that comply with clean-label standards, catering to consumers’ demand for natural and recognizable ingredients.
  2. Sustainable Sourcing: Companies are increasingly sourcing ingredients from sustainable origins, in response to growing environmental concerns and the need to meet regulatory requirements.
  3. Expansion in Emerging Markets: As disposable incomes rise in emerging economies, demand for premium texture-modified products in food, beverages, and cosmetics is expected to surge, opening new growth avenues for manufacturers.

The texture modifying agents market is set to undergo significant transformations as the demand for premium and functional textures grows across key sectors. With continuous R&D efforts and a focus on sustainability, this market presents substantial opportunities for innovation and growth over the next decade.

Country-wise Insights

The table below highlights revenue from product sales in key countries. United States and Germany are predicted to remain top consumers, with estimated trade valuations of USD 1,483.7 million and USD 1,187.0 million, respectively, by 2034.

Countries Market Value (2034)
United States USD 1,483.7 million
Germany USD 1,187.0 million
UK USD 890.2 million
China USD 494.6 million
India USD 692.4 million

Competition Outlook

The Texture Modifying Agents market is characterized by a dynamic and diverse competitive landscape, where leading manufacturers prioritize R&D, sustainable sourcing, and innovative formulations. Companies are increasingly committed to eco-friendly practices and securing product certifications to meet the rising demand for natural and sustainable ingredients.

This competitive space features numerous players differentiating themselves through product quality, pricing strategies, distribution networks, and innovation capabilities.

For example:

  • Under the brand name Naltive, Nexira launched a line of natural, plant-based texturizing agents tailored to the clean-label trend, enhancing the texture of various food products.
  • In 2021, Nexira expanded its capabilities by acquiring a Swiss-based company specializing in the production of locust bean gum and tara gum, strengthening its position as a global leader in natural texture modifiers.

Leading Texture Modifying Agents Brands

  • DuPont (IFF – International Flavors & Fragrances)
  • Cargill, Inc.
  • Tate & Lyle
  • Ingredion Incorporated
  • Ashland Global Holdings Inc.
  • Kerry Group
  • ADM (Archer Daniels Midland Company)
  • CP Kelco
  • BASF SE
  • Givaudan SA
  • DSM
  • Roquette Frères
  • Gelita AG
  • Nexira

Key Segments of Market Report

By Agent Type:

As per product type, the market has been categorized Thickeners (Starches (corn, potato), Hydrocolloids (guar gum, xanthan gum), Cellulose derivatives (CMC)), Gelling Agents (Gelatin, Agar-Agar, Pectin, Carrageenan), Emulsifiers (Lecithin, Mono- and diglycerides, Polysorbates), Stabilizers (Locust bean gum, Alginates), Humectants (Glycerol, Sorbitol, Propylene glycol), Fat Replacers (Modified starches, Proteins (whey protein, soy protein), Polydextrose), and Anti-Caking Agents (Silica, Calcium silicate, Magnesium stearate).

By Source:

As per source, the market has been categorized into Natural Texture Modifying Agents, Synthetic Texture Modifying Agents, and Microbial & Fermentation-Derived Agents.

By Functionality:

This segment is further categorized into Thickening, Gelling, Emulsifying, Stabilizing, Moisture Retention, Foaming, and Fat Replacement

By End Use Application:

As per end use application, the market has been categorized into Food & Beverages (Bakery & Confectionery, Dairy & Frozen Products, Sauces & Dressings, Beverages, Meat & Poultry, Plant-Based Alternatives, Functional Foods), Pharmaceuticals (Oral Formulations, Topical Formulations), Cosmetics & Personal Care (Skin Care, Hair Care, Makeup), Industrial Applications (Paints & Coatings, Lubricants & Adhesives), and Agriculture.

By Form:

This segment is further categorized into Powder, Liquid, Gel, and Granules.

By Region:

Industry analysis has been carried out in key countries of North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Cardiogenic Shock Treatment Market to Reach USD 1.77 Billion by 2033, Expanding at a CAGR of 7%: FMI Study

The global cardiogenic shock treatment market is poised for significant growth in the coming decade, with the market expected to reach a value of USD 1.77 Billion by 2033, up from USD 0.9 Billion in 2023. This represents a strong compound annual growth rate (CAGR) of 7% during the forecast period from 2023 to 2033.

One of the key drivers of market growth is the increasing incidence of heart disease worldwide. According to the World Health Organization, cardiovascular disease is the leading cause of death globally, accounting for 31% of all deaths. The growing prevalence of heart disease is contributing to a rising demand for effective treatment options for cardiogenic shock.

Another factor driving market growth is the increasing adoption of mechanical support devices such as Impella, ECMO, and IABPs. These devices provide mechanical support to the heart and help to restore blood flow and oxygen to the body’s organs. They have been shown to significantly improve survival rates and outcomes for patients with cardiogenic shock.

In addition to mechanical support devices, there are also several other medical devices and therapies that are being developed and tested for the treatment of cardiogenic shock, including extracorporeal carbon dioxide removal (ECCO2R) devices, microaxial flow pumps, and novel ventricular assist devices (VADs). These technologies have the potential to further improve outcomes for patients with cardiogenic shock and are expected to drive growth in the market.

Key Takeaways from the Market Study:

  • From 2018 to 2022, the Cardiogenic Shock Therapies market increased at a CAGR of 3.5%.
  • From 2023 to 2033, the market for cardiogenic shock treatments is projected to expand at a 7% CAGR.
  • The market for treatments for cardiogenic shock is anticipated to reach USD 1.77 billion by 2033.
  • The hospital sector holds the biggest market share, per the FMI research.
  • For Cardiogenic Shock Therapies, North America is predicted to have a 40% market share.
  • With a share of 20% throughout the projection period, it is expected that the East & South Asia market would grow considerably.

“A series of international level collaborations involving healthcare stakeholders across various institutional settings are fueling further clinical trials and research studies dedicated to discovering Cardiogenic Shock Treatments.” says an FMI analyst

Increased Market Insight Demand: Get Thorough Analysis and Trends in Our Complete Report!

Market Competition:

Key players in the market include companies such as Getinge AB, Par Pharmaceutical, Abbott, Viatris Inc., F. Hoffmann-La Roche Ltd,  Bayer AG, Terumo Corporation, Medtronic, AbioMed, Astrazeneca along with healthcare providers and technology companies among other global players.

  • In October 2022, the American Heart Association established the Cardiogenic Shock Registry, powered by Get With The Guidelines®, to provide a foundation for researchers, clinicians, and regulators to better understand the clinical symptoms, treatment patterns, and outcomes of different types of shock. The registry builds on over two decades of experience with the Get With The Guidelines® platform and will inform the medical community on how to best treat cardiogenic shock. The steering committee of the registry includes experts from leading academic surgeons and cardiologists, as well as representatives from the U.S. Food & Drug Administration and the U.S. Centers for Medicare & Medicaid Services, who provide guidance on establishing and managing the data in the registry.

Key Segments Profiled in the Cardiogenic Shock Treatment Industry Survey:

Treatment Type:

  • In-Vitro Test Kits
  • Drugs
  • Devices

End- User:

  • Cardiac Catheterization Labs
  • Hospitals
  • Ambulatory Surgical Centres

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Carcinoid Tumor Syndrome Management Market Poised for Robust Growth, Reaching USD 4993 Million by 2033 registering a CAGR of 10.9%

According to the latest market analysis by Future Market Insights, the global carcinoid tumor syndrome management market is set for substantial expansion over the next decade. From its valuation of USD 1774.38 million in 2023, the market is projected to grow at a compound annual growth rate (CAGR) of 10.9%, reaching approximately USD 4993 million by 2033.

This significant growth trajectory is underpinned by several key factors. The rising prevalence of carcinoid tumors, coupled with notable advancements in diagnostic and treatment methodologies, along with increased awareness among healthcare professionals and patients, are driving forces behind this market surge.

Carcinoid tumors, characterized by slow-growing neoplasms that can secrete hormone-like substances, present complex management challenges. However, the healthcare industry has made substantial strides in addressing these challenges. Innovations in diagnostic techniques have facilitated earlier and more accurate detection of CTS, which is imperative for effective management and treatment. Enhanced imaging technologies and biomarkers have revolutionized the diagnostic landscape, ensuring patients receive timely and precise diagnoses.

There have also been significant advancements in the development of treatment options for CTS. For example, somatostatin analogues (SSAs) such as octreotide and lanreotide are commonly used to control the symptoms of CTS by inhibiting the release of hormones from carcinoid tumors.

Other treatment options include chemotherapy, targeted therapy, and radiation therapy, depending on the type and stage of the tumor. As new therapies and treatment options continue to emerge, the demand for CTS management is likely to grow.

Key Takeaways from the Market Study:

  • The Carcinoid tumor syndrome management market is expected to grow at a value of 10.9% CAGR for the forecast period 2023-2033
  • Oral route of administration is expected to hold 55% of the market share in 2023 for Carcinoid tumor syndrome management market.
  • North America is expected to possess 44% market share for Carcinoid tumor syndrome management market in 2023.
  • Europe Carcinoid tumor syndrome management market size is expected to possess 37% market share in 2023.

“The rising awareness among patients and healthcare professionals is also contributing to the growth of the CTS management market. As patients become more informed about their condition and the available treatment options, they are more likely to seek out effective management options.” states an FMI analyst

Growing Need for Market Insights: Access Our Full Report for Thorough Analysis and Trends!

Competitive Landscape:

Key players in the Carcinoid tumor syndrome management are Novartis AG, Teva Pharmaceutical Industries Ltd, Mylan N.V., Ipsen Biopharmaceuticals, Inc, Sun Pharmaceutical Industries Ltd, Amgen Inc., Entrinsic Health Solutions, Inc., Endo Pharmaceuticals Inc., Sirtex SIR-Spheres Pty Ltd, BTG International Ltd

  • Mylan markets a somatostatin analog called Octreotide (brand name Sandostatin®), which is indicated for the treatment of symptoms associated with functional gastroenteropancreatic neuroendocrine tumors, including carcinoid syndrome.
  • Teva markets a somatostatin analog called Lanreotide (brand name Somatuline®), which is indicated for the treatment of symptoms associated with functional gastroenteropancreatic neuroendocrine tumors, including carcinoid syndrome.

Key Segments Profiled in the Carcinoid Tumor Syndrome Management Market Survey:

Organ Affected:

  • Small Intestine
  • Lungs
  • Rectum
  • Appendix
  • Stomach
  • Liver
  • Others

Therapy Type:

  • Chemotherapy
  • Biological Therapy
  • Radio Therapy

Drug:

  • Octreotide
  • Telotristat Etiprate
  • Lanreotide

Route of Administration:

  • Oral
  • Injectable

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube